Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine for progressive malignant glioma
ISRCTN45828668Phase 2Completed
- Sponsor
- University of Liège
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of 5-aminosalicylic acid + sulphasalazine in malignant glioma and astrocytoma, sponsored by University of Liège. Started Jun 2005; status: completed.
02
Drugs
5-aminosalicylic acid + sulphasalazine
03
Conditions
malignant gliomaastrocytoma
Beyond the preview
Go deeper on ISRCTN45828668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN45828668.